Chiesi Farmaceutici S.p.A.
PolandAll drugs from this manufacturer
-
It is used to treat symptoms (such as shortness of breath and wheezing) of moderate to severe bronchial asthma. It may also be used to relieve cough and shortness of breath in people with chronic obstructive pulmonary disease (COPD) who require long-term bronchodilator treatment.
Dosage form: solution, inhalation spray
Active substance Dosage formoterol fumarate 0.012 mg ATC: R03AC13
-
The medicine is used in patients with cystic fibrosis to treat chronic chest infections caused by Pseudomonas aeruginosa bacteria. It acts bactericidally, which helps to improve breathing.
Dosage form: solution for inhalation
Active substance Dosage tobramycin 300 mg ATC: J01GB01
-
The medicine is used for the treatment and prevention of respiratory distress syndrome (RDS) in newborns, especially premature infants, who are born with a deficiency of natural surfactant.
Dosage form: suspension for inhalation and bronchial use
Active substance Dosage poractant alfa 80 mg/ml ATC: R07AA02
-
The medicine is intended for the treatment of asthma in adults. It helps prevent symptoms such as shortness of breath, wheezing, and coughing, while simultaneously making breathing easier.
Dosage form: solution, inhalation spray
Active substance Dosage beclometasone dipropionate 200 mcg formoterol fumarate dihydrate 6 mcg ATC: R03AK08
-
The medicine is intended for the treatment of asthma in adults. It helps prevent symptoms such as shortness of breath, wheezing, and coughing.
Dosage form: solution, inhalation spray
Active substance Dosage beclometasone dipropionate anhydrous 200 mcg/dose formoterol fumarate dihydrate 6 mcg/dose ATC: R03AK08
-
The medicinal product is intended for the treatment of asthma in adults and for the relief of symptoms of severe chronic obstructive pulmonary disease (COPD) in adults.
Dosage form: powder for inhalation
Active substance Dosage beclometasone dipropionate 200 mcg/dose formoterol fumarate dihydrate 12 mcg/dose ATC: R03AK08